English
First Nasal Vaccine Developed by Bharat Biotech Gets Approval For Phase 2 And 3 Trials in India
India.com News Desk | Aug 13, 2021, 6:54 PM IST
As per the updates, Phase 1 clinical trial has been completed in age groups ranging 18 to 60 years.
By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts Cookies Policy.